Should You Buy Fly-E Group, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Fly-E Group, Inc. (FLYE) scores 4.6/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $1.71, our multi-model valuation analyzes whether the market has already discounted these weaknesses.
The short answer: 2 of 2 CirclFi valuation models project upside for Fly-E Group, Inc. (FLYE) at $1.71 — the model consensus leans bullish, with a Quality Score of 4.6/10 and Value-Trap risk of 57/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Fly-E Group, Inc. (FLYE) in 2026?
What Is the Bull Case vs the Bear Case for Fly-E Group, Inc. (FLYE)?
| Bull case — $4.93 target (+188.5%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +138.1% across 2 bullish models from the current price of $1.71. | No active model flags significant downside for FLYE. The Value Trap score of 57/100 still argues for some caution. |
| According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model targets a fair value of $4.93 (+188.5%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: software-defined vehicle revenue could provide meaningful support for Fly-E Group, Inc.'s revenue and margin trajectory in the Auto Manufacturers space. |
How Does FLYE Compare to Its Auto Manufacturers Peers?
Valuation data pages: PSNY · FFAI · VFS · AIEV · LCID · BINI · LOBO · XPEV · PEVM · RACE · TSLA
Which Other Stocks Score Like FLYE on Quality?
Closest companies to FLYE’s Quality of Company score of 4.6/10, across all industries.
- SNYR — Synergy CHC Corp. (QOC 4.6) · analysis
- OFS — OFS Capital Corporation (QOC 4.6) · analysis
- PTIX — Protagenic Therapeutics, Inc. (QOC 4.6) · analysis
- BDRX — Biodexa Pharmaceuticals Plc (QOC 4.6) · analysis
- RBOT — Vicarious Surgical Inc. (QOC 4.6) · analysis
- BKT — BlackRock Income Trust, Inc. (QOC 4.6) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Fly-E Group, Inc. (FLYE) Worth Buying in 2026?
The convergence of 4.6/10 quality, multi-model undervaluation (2/2 bullish, +138.1% median upside), and a median fair value of $4.07 vs. $1.71 current price makes Fly-E Group, Inc. one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.
These are quantitative model outputs, not investment recommendations. Fly-E Group, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About FLYE Stock?
Should I buy FLYE stock right now?
Based on CirclFi's multi-model analysis, 2 of 2 models see upside for FLYE at $1.71. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 4.6/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Fly-E Group, Inc.?
Key risks include: an elevated Value Trap score of 57/100, suggesting apparent undervaluation may mask deteriorating fundamentals; a below-average Quality Score of 4.6/10, indicating fundamental weakness; limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Auto Manufacturers companies. Always diversify and consult a financial advisor.
How does FLYE compare to its competitors?
Among Auto Manufacturers peers, FLYE holds a Quality Score of 4.6/10. Comparable companies include PSNY (QOC 4.8), FFAI (QOC 4.3), VFS (QOC 5.0). The relative ranking helps investors identify whether FLYE offers better fundamental quality than alternatives in the same sector.
Is FLYE a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. FLYE's Quality Score of 4.6/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy FLYE at?
CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $3.21 to $4.93. At $1.71, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for FLYE.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →